Nissan Chemical Corporation
Nissan Chemical Industries Ltd manufactures and sells chemicals, semiconductors, and pharmaceutical products.
Market cap
AUD8.1b
Enterprise valuation
AUD8.3b (Public information from Sep 2024)
Share price
JPY5193 4021.T
Tokyo Japan (HQ)
Financials
Estimates*
| JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 209.1b | 208.0b | 228.1b | 226.7b | 238.7b | 251.4b | 264.2b |
| % growth | 1 % | (1 %) | 10 % | (1 %) | 5 % | 5 % | 5 % |
| EBITDA | 55.1b | 64.8b | 67.8b | 66.9b | 68.7b | 73.3b | 78.0b |
| % EBITDA margin | 26 % | 31 % | 30 % | 30 % | 29 % | 29 % | 30 % |
| Profit | 33.5b | 38.8b | 41.1b | 38.0b | 40.4b | 42.9b | 46.1b |
| % profit margin | 16 % | 19 % | 18 % | 17 % | 17 % | 17 % | 17 % |
| EV / revenue | 4.0x | 4.9x | 3.7x | 3.6x | 3.0x | 2.8x | 2.7x |
| EV / EBITDA | 15.2x | 15.6x | 12.3x | 12.1x | 10.3x | 9.6x | 9.1x |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
